Trial Profile
Efficacy of low dose Rituximab with methotrexate compared to leflunomide with methotrexate in patients with refractory rheumatoid arthritis: A randomized double blind controlled clinical trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2019
Price :
$35
*
At a glance
- Drugs Leflunomide (Primary) ; Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms LORRA
- 11 Feb 2019 Status changed from completed to recruiting.
- 14 Sep 2011 New trial record